Publication:
National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease

dc.contributor.authorChangsirikulchai S.
dc.contributor.authorSangthawan P.
dc.contributor.authorJanma J.
dc.contributor.authorSripaiboonkij N.
dc.contributor.authorRattanamongkolgul S.
dc.contributor.authorThinkhamrop B.
dc.date.accessioned2021-04-05T03:21:46Z
dc.date.available2021-04-05T03:21:46Z
dc.date.issued2018
dc.date.issuedBE2561
dc.description.abstractAim: The aim of the present study was to evaluate the achievement in controlling the risk factors of cardiovascular diseases (CVD) in Thai patients with type 2 diabetes (T2DM) and chronic kidney disease (CKD). Methods: The DMHT dataset from 2011 to 2012, which was the cross-sectional study of the national survey in Thai patients with T2DM was analyzed. Results: There were 1254 of 15 149 diabetic patients with estimated glomerular filtration rate (eGFR) less than 60 mL/min per 1.73 m2 that had developed CVD for more than 12 months. The prevalence of CVD was 8.3%. The mean age in years was 68.2 with a standard deviation (SD) of 8.7. Males and females were 38.7 and 61.3%, respectively. The mean duration of diabetes was 8.5 (SD 0.2) years. The mean body mass index was 25.5 (SD 4.4) kg/m2. The percentage of patients with the target level of blood pressure control at ≤130/80 mm Hg was 47.1%. The percentage of patients who received angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) was 58.9%. The percentage of patients with the target level of LDL control at <70 mg/dL was 17.2%. The percentage of patients with the target level of HbA1C at 7% was 39.2%. There were 63 (5.0%) patients having recurrent CVD. Conclusions: Most Thai patients with T2DM and CKD with eGFR < 60 mL/min per 1.73 m2 could not achieve the therapeutic goals after the development of CVD. The national health policy should be planned to improve the quality of care to increase the number of patients who achieve the recommended goals. © 2016 Asian Pacific Society of Nephrology
dc.format.mimetypeapplication/pdf
dc.identifier.citationNephrology. Vol 23, No.1 (2018), p.53-59
dc.identifier.doi10.1111/nep.12922
dc.identifier.issn13205358
dc.identifier.other2-s2.0-85038085330
dc.identifier.urihttps://hdl.handle.net/20.500.14740/3869
dc.rights.holderScopus
dc.subject.otherAcetylsalicylic acid
dc.subject.otherAngiotensin receptor antagonist
dc.subject.otherClopidogrel
dc.subject.otherDipeptidyl carboxypeptidase inhibitor
dc.subject.otherHemoglobin A1c
dc.subject.otherAntidiabetic agent
dc.subject.otherAntihypertensive agent
dc.subject.otherAntilipemic agent
dc.subject.otherBiological marker
dc.subject.otherGlycosylated hemoglobin
dc.subject.otherHemoglobin A1c protein, human
dc.subject.otherLipid
dc.subject.otherAdult
dc.subject.otherAged
dc.subject.otherArticle
dc.subject.otherBody mass
dc.subject.otherCardiovascular disease
dc.subject.otherChronic kidney failure
dc.subject.otherControlled study
dc.subject.otherCross-sectional study
dc.subject.otherDisease association
dc.subject.otherEstimated glomerular filtration rate
dc.subject.otherFemale
dc.subject.otherHealth care policy
dc.subject.otherHuman
dc.subject.otherMajor clinical study
dc.subject.otherMale
dc.subject.otherNon insulin dependent diabetes mellitus
dc.subject.otherPopulation research
dc.subject.otherPrevalence
dc.subject.otherPriority journal
dc.subject.otherRecurrent disease
dc.subject.otherRisk factor
dc.subject.otherThai (people)
dc.subject.otherBlood
dc.subject.otherBlood pressure
dc.subject.otherCardiovascular disease
dc.subject.otherChronic kidney failure
dc.subject.otherDrug effect
dc.subject.otherDyslipidemia
dc.subject.otherFactual database
dc.subject.otherGlomerulus filtration rate
dc.subject.otherGlucose blood level
dc.subject.otherHealth care quality
dc.subject.otherHealth care survey
dc.subject.otherHealth status
dc.subject.otherHypertension
dc.subject.otherKidney
dc.subject.otherMetabolism
dc.subject.otherMiddle aged
dc.subject.otherNon insulin dependent diabetes mellitus
dc.subject.otherPathophysiology
dc.subject.otherRisk assessment
dc.subject.otherThailand
dc.subject.otherTime factor
dc.subject.otherTreatment outcome
dc.subject.otherAged
dc.subject.otherAntihypertensive Agents
dc.subject.otherBiomarkers
dc.subject.otherBlood Glucose
dc.subject.otherBlood Pressure
dc.subject.otherCardiovascular Diseases
dc.subject.otherCross-Sectional Studies
dc.subject.otherDatabases, Factual
dc.subject.otherDiabetes Mellitus, Type 2
dc.subject.otherDyslipidemias
dc.subject.otherFemale
dc.subject.otherGlomerular Filtration Rate
dc.subject.otherGlycated Hemoglobin A
dc.subject.otherHealth Care Surveys
dc.subject.otherHealth Status
dc.subject.otherHumans
dc.subject.otherHypertension
dc.subject.otherHypoglycemic Agents
dc.subject.otherHypolipidemic Agents
dc.subject.otherKidney
dc.subject.otherLipids
dc.subject.otherMale
dc.subject.otherMiddle Aged
dc.subject.otherPrevalence
dc.subject.otherQuality Indicators, Health Care
dc.subject.otherRenal Insufficiency, Chronic
dc.subject.otherRisk Assessment
dc.subject.otherRisk Factors
dc.subject.otherThailand
dc.subject.otherTime Factors
dc.subject.otherTreatment Outcome
dc.titleNational survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85038085330&doi=10.1111%2fnep.12922&partnerID=40&md5=bfec910d0ce02dec2d2e76bd20093058

Files